AAA: Auricular Acupressure for Perimenopausal Women With Anxiety

Sponsor
Chang-Hua Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01056458
Collaborator
China Medical University Hospital (Other)
90
1
2
12
7.5

Study Details

Study Description

Brief Summary

This study is expected to show auricular acupressure therapy help to improve the anxiety symptoms of perimenopausal and early postmenopausal women, looking forward to developing a convenient, safe and effective way to reduce the use of sedative hypnotics and their dependencies, thereby improving their quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: auricular acupressure
  • Other: sham acupressure
N/A

Detailed Description

There are several stages of women while they were particularly vulnerable to anxiety and insomnia , especially in the pre-menstruation, pregnancy, postpartum, and menopause stage. Sleep problems are common in menopausal and postmenopausal women, its prevalence can be based on research from 15% to 60%. As for anxiety, the prevalence of women in this population can reach 53.7%. Several studies overseas have already pointed out that the improvement of acupuncture for anxiety disorders have had pretty good results. As auricular acupressure with a simple operation and the advantages of non-invasive, our interest is to explore the clinical benefit of combined auricular acupressure and medical therapy on anxiety and insomnia improvement in menopausal and early post-menopausal women. We design a double-blind, randomized controlled study, the subjects are ninety 40 to 60 years old women, during perimenopause and early postmenopause who are accompanied by anxiety symptoms. They were randomly divided into experimental and control groups, use the tape of ear adhesive beads on shenmen and subcortical area of both ears after three meals and before bed for three minutes each area with alternating ears, twice a week to replace paste. A total treatment time is eight times and a total of four weeks. Primary efficacy assessment (primary outcome measure) for the Hamilton Anxiety Rating Scale (HAMA) total score change. Secondary efficacy assessments (secondary outcome measure) for: 1) Menopause Rating Scale (MRS) scores; 2) Short Form Health Survey (SF-36) scores; 3) Clinical Global Impression-Severity (CGI-S) scores; and 4) Clinical Global Impression-Improvement (CGI-I) score changes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effect of Auricular Acupressure on Perimenopausal and Early Postmenopausal Women With Anxiety: a Double Blinded, Randomized and Controlled Study
Study Start Date :
Jan 1, 2010
Anticipated Primary Completion Date :
Jan 1, 2011
Anticipated Study Completion Date :
Jan 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Acupressure acupressure

Other: auricular acupressure
use the tape of ear adhesive beads on shenmen and subcortical area of both ears after three meals and before bed for three minutes each area with alternating ears, twice a week to replace paste.
Other Names:
  • acupressure
  • Sham Comparator: sham acupressure

    Other: sham acupressure
    use only tape without ear adhesive beads under the same ways
    Other Names:
  • acupressure
  • Outcome Measures

    Primary Outcome Measures

    1. Hamilton Anxiety Rating Scale [4 weeks aftter ear acupressure]

    Secondary Outcome Measures

    1. Menopause Rating Scale,Short Form Health Survey(SF-36),CGI [4 weeks aftter ear acupressure]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 60 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age between 40 to 60 years

    • irregular menstrual cycle less than 12 months or no menstrual cycle less than 10 years

    • FSH level>= 14 IU/L

    • Brief symptom rating scale total scores>= 6

    Exclusion Criteria:
    • severe medical conditions

    • substance dependence or abuse

    • contraindication of BZDs

    • contraindication of acupressure

    • other primary anxiety disorder and major psychosis

    • use hormone therapy

    • use herb medicine

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Chang-Hua Hospital Changhua Taiwan 513

    Sponsors and Collaborators

    • Chang-Hua Hospital
    • China Medical University Hospital

    Investigators

    • Principal Investigator: Ching-Ling Kao, MD, Chang-Hua Hospital, Department of Health

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01056458
    Other Study ID Numbers:
    • 98DMR291
    First Posted:
    Jan 26, 2010
    Last Update Posted:
    May 31, 2010
    Last Verified:
    Jan 1, 2010

    Study Results

    No Results Posted as of May 31, 2010